SPONSOR
Bayer
Total Trials
6
Recruiting
6
Phases
Phase 1, Phase 3
Conditions studied: Metastatic Hormonesensitive Prostate Cancer (mHSPC)Chronic Kidney DiseaseType 2 Diabetes MellitusNeovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)Vasomotor Symptoms as a Sex Hormone-dependent Disorder in WomenDrug-drug InteractionAdvanced Non-small Cell Lung Cancer, HER2 Mutation
Bayer is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Metastatic Hormonesensitive Prostate Cancer (mHSPC), Chronic Kidney Disease, Type 2 Diabetes Mellitus, Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO).
The trial portfolio spans Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Bayer
How many clinical trials has Bayer sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Bayer, of which 6 are actively recruiting participants. These trials cover conditions including Metastatic Hormonesensitive Prostate Cancer (mHSPC), Chronic Kidney Disease, Type 2 Diabetes Mellitus. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Bayer research focus on?
Bayer clinical trials span Metastatic Hormonesensitive Prostate Cancer (mHSPC), Chronic Kidney Disease, Type 2 Diabetes Mellitus, Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO), Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women, and additional conditions. The research pipeline includes Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Bayer clinical trial?
To participate in a Bayer trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Bayer trials with current recruitment status updated daily.
Clinical Trials by Bayer
NCT07223372
Recruiting
An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia
Metastatic Hormonesensitive Prostate Cancer (mHSPC)
NCT07232537
Recruiting
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
Chronic Kidney Disease
NCT07308639
Recruiting
DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.
Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)
NCT07762287 Phase 1
Recruiting
Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study Participants
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women
NCT07652723 Phase 1
Recruiting
A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants
Drug-drug Interaction
NCT06452277 Phase 3
Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Non-small Cell Lung Cancer, HER2 Mutation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology